Clotting Problems: Diagnosis and Management of Underlying Coagulopathies

Seminars in Vascular Surgery

Volumn 23, Issue 4, 2010, Pages 221-227

  Houbballah, Rabih ^a   LaMuraglia, Glenn M ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ACTIVATED PROTEIN C; ANTICOAGULANT AGENT; ANTITHROMBIN III; ANTIVITAMIN K; ARGATROBAN; BATROXOBIN; BETA2 GLYCOPROTEIN 1; BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 5 LEIDEN; BLOOD CLOTTING FACTOR 8; CLOPIDOGREL; FIBRINOGEN; HEPARIN; HEPARIN PLATELET FACTOR 4 ANTIBODY; HIRULOG; HOMOCYSTEINE; IBUPROFEN; LEPIRUDIN; LIPOPROTEIN A; NAPROXEN; OMEPRAZOLE; ORAL CONTRACEPTIVE AGENT; PHOSPHOLIPID ANTIBODY; PROTEIN S; PROTHROMBIN; THROMBIN;

ANTIPHOSPHOLIPID SYNDROME; ANTITHROMBIN III DEFICIENCY; ARTERY THROMBOSIS; ARTICLE; BLOOD CLOTTING DISORDER; DISEASE ASSOCIATION; DRUG ANTAGONISM; DRUG MEGADOSE; DRUG RESISTANCE; DYSFIBRINOGENEMIA; FIBRINOLYSIS; GENE EXPRESSION; GENE FUNCTION; GENE MUTATION; HEPARIN INDUCED THROMBOCYTOPENIA; HEREDITY; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HYPERCOAGULABILITY; HYPERHOMOCYSTEINEMIA; MALIGNANT NEOPLASTIC DISEASE; PATHOPHYSIOLOGY; PATIENT CARE; PRACTICE GUIDELINE; PREGNANCY; PRIORITY JOURNAL; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; RISK FACTOR; THROMBOPHILIA; THROMBOSIS; VENOUS THROMBOEMBOLISM;

ANTICOAGULANTS; BLOOD COAGULATION DISORDERS; DIAGNOSTIC TECHNIQUES, CARDIOVASCULAR; HUMANS; PROGNOSIS; THROMBECTOMY; THROMBOSIS;

EID: 78650620981     PISSN: 08957967     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semvascsurg.2010.11.001     Document Type: Article

References (28)

1. Dahlback B. Advances in understanding pathogenic mechanisms of thrombophilic disorders. Blood 2008, 112:19-27.
2. Bick R.L. Hereditary and acquired thrombophilic disorders. Clin Appl Thromb Hemost 2006, 12:125-135.
3. de Moerloose P., Boehlen F. Inherited thrombophilia in arterial disease: a selective review. Semin Hematol 2007, 44:106-113.
4. Martinelli I., Bucciarelli P., Mannucci P.M. Thrombotic risk factors: basic pathophysiology. Crit Care Med 2010, 38(suppl):S3-S9.
5. Lensen R., Rosendaal F., Vandenbroucke J., Bertina R. Factor V Leiden: the venous thrombotic risk in thrombophilic families. Br J Haematol 2000, 110:939-945.
6. Baglin T., Gray E., Greaves M., et al. Clinical guidelines for testing for heritable thrombophilia. Br J Haematol 2010, 149:209-220.
7. Foy P., Moll S. Thrombophilia: 2009 update. Curr Treat Options Cardiovasc Med 2009, 11:114-128.
8. Kraaijenhagen R.A., in't Anker P.S., Koopman M.M., et al. High plasma concentration of factor VIIIc is a major risk factor for venous thromboembolism. Thromb Haemost 2000, 83:5-9.
9. Patnaik M.M., Moll S. Inherited antithrombin deficiency: a review. Haemophilia 2008, 14:1229-1239.
10. Goldenberg N.A., Manco-Johnson M.J. Protein C deficiency. Haemophilia 2008, 14:1214-1221.
11. ten Kate M.K., van der Meer J. Protein S deficiency: a clinical perspective. Haemophilia 2008, 14:1222-1228.
12. Meltzer M.E., Doggen C.J., de Groot P.G., Rosendaal F.R., Lisman T. Fibrinolysis and the risk of venous and arterial thrombosis. Curr Opin Hematol 2007, 14:242-248.
13. den Heijer M., Rosendaal F.R., Blom H.J., Gerrits W.B., Bos G.M. Hyperhomocysteinemia and venous thrombosis: a meta-analysis. Thromb Haemost 1998, 80:874-877.
14. Ray J.G., Kearon C., Yi Q., Sheridan P., Lonn E. Homocysteine-lowering therapy and risk for venous thromboembolism: a randomized trial. Ann Intern Med 2007, 146:761-767.
15. Lim W. Antiphospholipid antibody syndrome. Hematology Am Soc Hematol Educ Program 2009, 233-229.
16. Linenberger M.L., Wittkowsky A.K. Thromboembolic complications of malignancy. Part 1: Risks. Oncology (Williston Park) 2005, 19:853-861.
17. Linenberger M.L., Wittkowsky A.K. Thromboembolic complications of malignancy. Part 2: management. Oncology (Williston Park) 2005, 19:1077-1084. discussion 1084, 1087-1088.
18. Arepally G.M., Ortel T.L. Heparin-induced thrombocytopenia. Annu Rev Med 2010, 61:77-90.
19. Warkentin T.E., Greinacher A., Koster A., Lincoff A.M. Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008, 133(suppl):340S-380S.
20. Ben-Dor I., Kleiman N.S., Lev E. Assessment, mechanisms, and clinical implication of variability in platelet response to aspirin and clopidogrel therapy. Am J Cardiol 2009, 104:227-233.
21. Kasotakis G., Pipinos I.I., Lynch T.G. Current evidence and clinical implications of aspirin resistance. J Vasc Surg 2009, 50:1500-1510.
22. Rosendaal F.R., Helmerhorst F.M., Vandenbroucke J.P. Female hormones and thrombosis. Arterioscler Thromb Vasc Biol 2002, 22:201-210.
23. Biswas A., Ranjan R., Meena A., et al. Prothrombotic factors and the risk of acute onset non-cardioembolic stroke in young Asian Indians. Thromb Res 2009, 124:397-402.
24. De Stefano V., Chiusolo P., Paciaroni K., et al. Prothrombin G20210A mutant genotype is a risk factor for cerebrovascular ischemic disease in young patients. Blood 1998, 91:3562-3565.
25. Mahmoodi B.K., Brouwer J.L., Veeger N.J., van der Meer J. Hereditary deficiency of protein C or protein S confers increased risk of arterial thromboembolic events at a young age: results from a large family cohort study. Circulation 2008, 118:1659-1667.
26. Monahan T.S., Owens C.D. Risk factors for lower-extremity vein graft failure. Semin Vasc Surg 2009, 22:216-226.
27. Vig S., Chitolie A., Sleight S., et al. Prevalence and risk of thrombophilia defects in vascular patients. Eur J Vasc Endovasc Surg 2004, 28:124-131.
28. Singh N., Sidawy A.N., DeZee K.J., Neville R.F., Akbari C., Henderson W. Factors associated with early failure of infrainguinal lower extremity arterial bypass. J Vasc Surg 2008, 47:556-561.